Application of Mini-Programs in Long-Term Management of Epilepsy in Rural Areas
Research on the Application of Mobile Health Management Mini-Programs in Long-Term Management of Epilepsy in Rural Areas
This project, titled " Research on the Application of Mobile Health Management Mini-Programs in Long-Term Management of Epilepsy in Rural Areas", is led by the First Affiliated Hospital of Air Force Medical University, with Jiang Wen as the principal investigator. It is a prospective, multicenter, cluster-randomized controlled trial involving 1276 patients from eight rural counties in China's northwest region. This study aims to establish a new scheme for improving epilepsy management in rural areas of Northwest China by combining remote mobile health management technology. The primary objective is to evaluate the effectiveness of the remote medical management model using a mobile health management mini-program in improving the self-management ability of rural epilepsy patients; secondary objectives include evaluating the impact of this model on patients' medication adherence, quality of life, health status, and frequency of epileptic seizures. Key components include patient and doctor interfaces for features like medication reminders, and seizure records. The trial runs from December 1, 2025, to November 30, 2028, with primary outcomes measured at 6 and12 months and secondary outcomes assessing medication adherence, quality of life, and safety.
Studieoversikt
Status
Status
Forhold
Forhold
Intervensjon / Behandling
Intervensjon / Behandling
Studietype
Studietype
Registrering (Antatt)
Registrering
Fase
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Shaanxi
-
Xi'an, Shaanxi, Kina, 710032
- Department of Neurology, Xijing Hospital, Air Force Medical University
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Patient inclusion criteria:
- Meet the diagnostic criteria for epilepsy established by the International League Against Epilepsy (ILAE).
- Participate in the national rural epilepsy prevention and management project.
- Aged 18 to 64.
- The patient or their primary caregiver possesses a smartphone and is capable of using WeChat.
- Volunteer to participate in the study and sign a written informed consent form.
Patient exclusion criteria:
- Women who plan to become pregnant, are in pregnancy, or are breastfeeding.
- The seizures are caused by clear and reversible triggers.
- Those who have achieved epilepsy remission criteria and currently do not require long-term antiepileptic drug management.
- Severe infections, malignant tumors, severe dysfunction of heart, liver, and kidney functions, or severe physical diseases that the researcher believes will significantly affect epilepsy management, outcome evaluation, or follow-up completion.
- Individuals with severe mental, cognitive, or communication impairments who are unable to cooperate with research and remote management.
- It is expected that the participant will not be able to complete the required follow-up visits, or the investigator deems the participant unsuitable for participation in this study.
- Have participated in any other clinical trials within the past 6 months.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Helsetjenesteforskning
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Firemannsrom
Antall våpen
Våpen og intervensjoner
Deltakergruppe / ArmDeltakergruppe / Arm |
Intervensjon / BehandlingIntervensjon / Behandling |
|---|---|
|
Ingen inngripen: Standard Landlig Epilepsibehandling
|
|
|
Eksperimentell: Forbedret administrasjon med mobilapp
|
Patient Module: Real-time monitoring, medication reminders, seizure logging, educational resources. Physician Module: remote follow-up, data analytics dashboard. |
Hva måler studien?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Epilepsy Self Management Scale Score
Tidsramme: 6 and 12 months
|
Evaluation method: The Chinese version of the Epilepsy Self Management Scale was used. This scale includes multiple dimensions (such as drug management, information management, safety management, etc.), and a higher total score indicates stronger self-management ability. |
6 and 12 months
|
Samarbeidspartnere og etterforskere
Sponsor
Sponsor
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Studiestart
Primær fullføring (Antatt)
Primær fullføring
Studiet fullført (Antatt)
Studiet fullført
Datoer for studieregistrering
Først innsendt
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Først lagt ut
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Sist oppdatering lagt ut
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
Andre studie-ID-numre
- XJLL-KY-20252555
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
IPD will not be shared due to privacy constraints, contractual agreements.
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
produkt produsert i og eksportert fra USA
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .